Apotea AB Statistics
Total Valuation
Apotea AB has a market cap or net worth of SEK 8.98 billion. The enterprise value is 9.22 billion.
| Market Cap | 8.98B |
| Enterprise Value | 9.22B |
Important Dates
The next estimated earnings date is Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Apotea AB has 104.07 million shares outstanding. The number of shares has increased by 562.98% in one year.
| Current Share Class | 104.07M |
| Shares Outstanding | 104.07M |
| Shares Change (YoY) | +562.98% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 0.45% |
| Owned by Institutions (%) | 59.32% |
| Float | 73.29M |
Valuation Ratios
The trailing PE ratio is 58.87 and the forward PE ratio is 30.45.
| PE Ratio | 58.87 |
| Forward PE | 30.45 |
| PS Ratio | 1.27 |
| PB Ratio | 10.60 |
| P/TBV Ratio | 11.47 |
| P/FCF Ratio | 59.67 |
| P/OCF Ratio | 21.06 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.61, with an EV/FCF ratio of 61.29.
| EV / Earnings | 35.07 |
| EV / Sales | 1.30 |
| EV / EBITDA | 19.61 |
| EV / EBIT | 28.03 |
| EV / FCF | 61.29 |
Financial Position
The company has a current ratio of 1.18, with a Debt / Equity ratio of 0.38.
| Current Ratio | 1.18 |
| Quick Ratio | 0.47 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 0.68 |
| Debt / FCF | 2.13 |
| Interest Coverage | 31.02 |
Financial Efficiency
Return on equity (ROE) is 36.56% and return on invested capital (ROIC) is 21.25%.
| Return on Equity (ROE) | 36.56% |
| Return on Assets (ROA) | 10.91% |
| Return on Invested Capital (ROIC) | 21.25% |
| Return on Capital Employed (ROCE) | 29.66% |
| Revenue Per Employee | 9.79M |
| Profits Per Employee | 362,983 |
| Employee Count | 800 |
| Asset Turnover | 3.76 |
| Inventory Turnover | 7.60 |
Taxes
In the past 12 months, Apotea AB has paid 60.90 million in taxes.
| Income Tax | 60.90M |
| Effective Tax Rate | 18.92% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 88.37 |
| 200-Day Moving Average | 90.62 |
| Relative Strength Index (RSI) | 46.62 |
| Average Volume (20 Days) | 184,149 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Apotea AB had revenue of SEK 7.09 billion and earned 262.80 million in profits. Earnings per share was 1.47.
| Revenue | 7.09B |
| Gross Profit | 1.96B |
| Operating Income | 328.80M |
| Pretax Income | 321.90M |
| Net Income | 262.80M |
| EBITDA | 406.70M |
| EBIT | 328.80M |
| Earnings Per Share (EPS) | 1.47 |
Balance Sheet
The company has 97.70 million in cash and 321.10 million in debt, giving a net cash position of -223.40 million or -2.15 per share.
| Cash & Cash Equivalents | 97.70M |
| Total Debt | 321.10M |
| Net Cash | -223.40M |
| Net Cash Per Share | -2.15 |
| Equity (Book Value) | 846.80M |
| Book Value Per Share | 7.95 |
| Working Capital | 204.10M |
Cash Flow
In the last 12 months, operating cash flow was 426.20 million and capital expenditures -275.80 million, giving a free cash flow of 150.40 million.
| Operating Cash Flow | 426.20M |
| Capital Expenditures | -275.80M |
| Free Cash Flow | 150.40M |
| FCF Per Share | 1.45 |
Margins
Gross margin is 27.60%, with operating and profit margins of 4.64% and 3.71%.
| Gross Margin | 27.60% |
| Operating Margin | 4.64% |
| Pretax Margin | 4.54% |
| Profit Margin | 3.71% |
| EBITDA Margin | 5.74% |
| EBIT Margin | 4.64% |
| FCF Margin | 2.12% |
Dividends & Yields
Apotea AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -562.98% |
| Shareholder Yield | -562.98% |
| Earnings Yield | 2.93% |
| FCF Yield | 1.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Apotea AB has an Altman Z-Score of 8.12 and a Piotroski F-Score of 5.
| Altman Z-Score | 8.12 |
| Piotroski F-Score | 5 |